J P Kushner Selected Research

Porphyria Cutanea Tarda

7/2009	Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases.
7/2009	Longitudinal study of a mouse model of familial porphyria cutanea tarda.
12/2001	Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase.
1/2001	A mouse model of familial porphyria cutanea tarda.
12/2000	Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda.
11/2000	CYP3A-inducing agents and the attenuation of uroporphyrin accumulation and excretion in a rat model of porphyria cutanea tarda.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J P Kushner Research Topics

Disease

6	Porphyria Cutanea Tarda 07/2009 - 11/2000
5	Hemochromatosis (Bronze Diabetes) 11/2006 - 03/2000
2	Iron Overload 11/2006 - 01/2001
2	Insulin Resistance 11/2006 - 07/2006
2	Fibrosis (Cirrhosis) 11/2000 - 03/2000
1	Eosinophilic Esophagitis 09/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2014
1	Hypersensitivity (Allergy) 09/2014
1	Porphyrias (Porphyria) 01/2001
1	Skin Diseases (Skin Disease) 01/2001
1	Anemia 01/2001
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2001
1	Iron Deficiencies 01/2001
1	Refractory Anemia 01/2001
1	Thalassemia 01/2001
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2000
1	Joint Diseases (Joint Disease) 11/2000
1	Inflammation (Inflammations) 03/2000

Drug/Important Bio-Agent (IBA)

5	IronIBA 07/2009 - 03/2000
3	Uroporphyrinogen Decarboxylase (Uroporphyrinogen III Decarboxylase)IBA 07/2009 - 01/2001
2	Glucose (Dextrose)FDA LinkGeneric 11/2006 - 07/2006
2	Insulin (Novolin)FDA Link 11/2006 - 07/2006
1	AntigensIBA 09/2014
1	RNA (Ribonucleic Acid)IBA 09/2014
1	CytochromesIBA 07/2009
1	PorphyrinsIBA 01/2001
1	Iron Chelating AgentsIBA 01/2001
1	Oral ContraceptivesIBA 12/2000
1	TransferasesIBA 11/2000
1	Transferrin (beta 2 Transferrin)IBA 11/2000
1	Polychlorinated Biphenyls (PCBs)IBA 11/2000
1	Chlorodiphenyl (54% Chlorine)IBA 11/2000
1	Aminolevulinic Acid (Levulan)FDA Link 11/2000
1	Drinking WaterIBA 11/2000
1	Estrogens (Estrogen)FDA Link 03/2000

Therapy/Procedure

1	Chelation Therapy (Therapy, Chelation) 01/2001
1	Therapeutics 01/2001
1	Estrogen Replacement Therapy 12/2000